Principal Street Partners, LLC Bristol Myers Squibb CO Transaction History

Principal Street Partners, LLC

$615 Million
Q3 2024

A detailed history of Principal Street Partners, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Principal Street Partners, LLC holds 118,215 shares of BMY stock, worth $6.96 Million. This represents 1.0% of its overall portfolio holdings.

Number of Shares

118,215

Previous 132,022 10.46%

Holding current value

$6.96 Million

Previous $5.48 Million 11.58%

% of portfolio

1.0%

Previous 0.99%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$39.66 - $51.75 $547,585 - $714,512	-13,807 Reduced 10.46%	118,215 $6.12 Million
Q2 2024 Aug 14, 2024	SELL	$40.25 - $52.99 $204,148 - $268,765	-5,072 Reduced 3.7%	132,022 $5.48 Million
Q1 2024 May 15, 2024	BUY	$47.98 - $54.4 $2.7 Million - $3.06 Million	56,188 Added 69.45%	137,094 $7.43 Million
Q4 2023 Feb 07, 2024	BUY	$48.48 - $57.85 $56,963 - $67,973	1,175 Added 1.47%	80,906 $4.15 Million
Q3 2023 Nov 01, 2023	BUY	$57.89 - $64.73 $293,849 - $328,569	5,076 Added 6.8%	79,731 $4.63 Million
Q2 2023 Aug 21, 2023	SELL	$63.71 - $70.74 $209,605 - $232,734	-3,290 Reduced 4.22%	74,655 $4.77 Million
Q1 2023 May 11, 2023	BUY	$65.71 - $74.53 $146,007 - $165,605	2,222 Added 2.93%	77,945 $5.4 Million
Q4 2022 Feb 15, 2023	BUY	$68.48 - $81.09 $36,979 - $43,788	540 Added 0.72%	75,723 $5.45 Million
Q3 2022 Nov 14, 2022	SELL	$0.13 - $76.84 $274 - $162,286	-2,112 Reduced 2.73%	75,183 $5.35 Million
Q2 2022 Aug 15, 2022	SELL	$72.62 - $79.98 $1.2 Million - $1.33 Million	-16,581 Reduced 17.66%	77,295 $5.95 Million
Q1 2022 May 05, 2022	BUY	$61.48 - $73.72 $318,220 - $381,574	5,176 Added 5.84%	93,876 $6.86 Million
Q4 2021 Feb 07, 2022	BUY	$53.63 - $62.52 $736,339 - $858,399	13,730 Added 18.31%	88,700 $5.53 Million
Q3 2021 Nov 10, 2021	SELL	$59.17 - $69.31 $143,132 - $167,660	-2,419 Reduced 3.13%	74,970 $4.44 Million
Q2 2021 Aug 10, 2021	SELL	$61.91 - $67.42 $7.26 Million - $7.91 Million	-117,340 Reduced 60.26%	77,389 $5.17 Million
Q1 2021 May 13, 2021	BUY	$59.34 - $66.74 $7.26 Million - $8.16 Million	122,296 Added 168.84%	194,729 $12.3 Million
Q4 2020 Feb 16, 2021	SELL	$57.74 - $65.43 $378,774 - $429,220	-6,560 Reduced 8.3%	72,433 $4.49 Million
Q3 2020 Nov 12, 2020	SELL	$57.43 - $63.64 $378,004 - $418,878	-6,582 Reduced 7.69%	78,993 $4.76 Million
Q2 2020 Aug 14, 2020	SELL	$54.82 - $64.09 $1.76 Million - $2.06 Million	-32,176 Reduced 27.33%	85,575 $5.03 Million
Q1 2020 May 14, 2020	SELL	$46.4 - $67.43 $1.83 Million - $2.67 Million	-39,537 Reduced 25.14%	117,751 $6.56 Million
Q4 2019 Mar 04, 2020	BUY	$49.21 - $64.19 $309,776 - $404,076	6,295 Added 4.17%	157,288 $10.1 Million
Q3 2019 Nov 14, 2019	BUY	$42.77 - $50.71 $6.46 Million - $7.66 Million	150,993 New	150,993 $7.66 Million

Others Institutions Holding BMY

# of Institutions

2,533

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Street Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Principal Street Partners, LLC with notifications on news.

Account

Principal Street Partners, LLC Bristol Myers Squibb CO Transaction History